Study protocol for a cluster-randomised controlled trial of an NCD access to medicines initiative: evaluation of Novartis Access in Kenya

被引:14
|
作者
Rockers, Peter C. [1 ]
Wirtz, Veronika J. [1 ]
Vian, Taryn [1 ]
Onyango, Monica A. [1 ]
Ashigbie, Paul G. [1 ]
Laing, Richard [1 ,2 ]
机构
[1] Boston Univ, Dept Global Hlth, Sch Publ Hlth, Boston, MA 02215 USA
[2] Univ Western Cape, Sch Publ Hlth, Cape Town, South Africa
来源
BMJ OPEN | 2016年 / 6卷 / 11期
关键词
NONCOMMUNICABLE DISEASES; BASE-LINE;
D O I
10.1136/bmjopen-2016-013386
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction: Novartis recently launched Novartis Access, an initiative to provide a basket of reduced price medicines for non-communicable diseases (NCDs) to be sold through the public and private non-profit sectors in programme countries. This study will evaluate the impact of Novartis Access on the availability and price of NCD medicines at health facilities and households in Kenya, the first country to receive the programme. Methods and analysis: This study will be a cluster-randomised controlled trial. 8 counties in Kenya will be randomly assigned to the intervention or control group using a covariate constrained randomisation method to maximise balance on demographic and health characteristics. In intervention counties, public and private non-profit health facilities will be able to order Novartis Access NCD medicines from the Mission for Essential Drugs and Supplies (MEDS). Data will be collected from a random sample of 384 health facilities and 800 households at baseline, midline after 1-year of intervention, and end-line after 2 years. Quarterly surveillance data will also be collected from health facilities and a subsample of households through phone-based interviews. Households will be eligible if at least one resident has been previously diagnosed and prescribed a medicine for an NCD addressed by Novartis Access, including hypertension and diabetes. The primary outcomes will be availability and price of NCD medicines at health facilities, and availability, price, and expenditures on NCD medicines at households. Impacts will be estimated using intention-to-treat analysis. Ethics and dissemination: This protocol was approved by the Institutional Review Boards at Strathmore University and at Boston University. Informed consent will be obtained from all participants at the start of the trial. The findings of the trial will be disseminated through peer-reviewed journals, international conferences, and meetings and events organised with local stakeholders.
引用
收藏
页数:7
相关论文
共 50 条
  • [1] Effect of Novartis Access on availability and price of non-communicable disease medicines in Kenya: a cluster-randomised controlled trial
    Rockers, Peter C.
    Laing, Richard O.
    Ashigbie, Paul G.
    Onyango, Monica A.
    Mukiira, Carol K.
    Wirtz, Veronikaj
    [J]. LANCET GLOBAL HEALTH, 2019, 7 (04): : E492 - E502
  • [2] Effectiveness of an mHealth system on access to eye health services in Kenya: a cluster-randomised controlled trial
    Rono, Hillary
    Bastawrous, Andrew
    Macleod, David
    Mamboleo, Ronald
    Bunywera, Cosmas
    Wanjala, Emmanuel
    Gichuhi, Stephen
    Burton, Matthew J.
    [J]. LANCET DIGITAL HEALTH, 2021, 3 (07): : E414 - E424
  • [3] Increasing access to care for sick newborns: evidence from the Ghana Newhints cluster-randomised controlled trial
    Manu, Alexander
    Hill, Zelee
    ten Asbroek, Augustinus H. A.
    Soremekun, Seyi
    Weobong, Benedict
    Gyan, Thomas
    Tawiah-Agyemang, Charlotte
    Danso, Samuel
    Amenga-Etego, Seeba
    Owusu-Agyei, Seth
    Kirkwood, Betty R.
    [J]. BMJ OPEN, 2016, 6 (06):
  • [4] Evaluation of the SPIRIT Integrated Suicide Prevention Programme: study protocol for a cluster-randomised controlled trial in rural Gujarat, India
    Pathare, Soumitra
    Shields-Zeeman, Laura
    Vijayakumar, Lakshmi
    Pandit, Deepa
    Nardodkar, Renuka
    Chatterjee, Susmita
    Kalha, Jasmine
    Krishnamoorthy, Sadhvi
    Jain, Nikhil
    Kapoor, Arjun
    Shahjahan, Mohammad
    Chauhan, Ajay
    Smit, Filip
    [J]. TRIALS, 2020, 21 (01)
  • [5] Evaluation of the SPIRIT Integrated Suicide Prevention Programme: study protocol for a cluster-randomised controlled trial in rural Gujarat, India
    Soumitra Pathare
    Laura Shields-Zeeman
    Lakshmi Vijayakumar
    Deepa Pandit
    Renuka Nardodkar
    Susmita Chatterjee
    Jasmine Kalha
    Sadhvi Krishnamoorthy
    Nikhil Jain
    Arjun Kapoor
    Mohammad Shahjahan
    Ajay Chauhan
    Filip Smit
    [J]. Trials, 21
  • [6] Sinako, a study on HIV competent households in South Africa: a cluster-randomised controlled trial protocol
    Caroline Masquillier
    Lucia Knight
    Linda Campbell
    Neo Sematlane
    Anton Delport
    Tanyaradzwa Dube
    Edwin Wouters
    [J]. Trials, 21
  • [7] Sinako, a study on HIV competent households in South Africa: a cluster-randomised controlled trial protocol
    Masquillier, Caroline
    Knight, Lucia
    Campbell, Linda
    Sematlane, Neo
    Delport, Anton
    Dube, Tanyaradzwa
    Wouters, Edwin
    [J]. TRIALS, 2020, 21 (01)
  • [8] Mass mosquito trapping for malaria control in western Kenya: study protocol for a stepped wedge cluster-randomised trial
    Hiscox, Alexandra
    Homan, Tobias
    Mweresa, Collins K.
    Maire, Nicolas
    Di Pasquale, Aurelio
    Masiga, Daniel
    Oria, Prisca A.
    Alaii, Jane
    Leeuwis, Cees
    Mukabana, Wolfgang R.
    Takken, Willem
    Smith, Thomas A.
    [J]. TRIALS, 2016, 17
  • [9] Mass mosquito trapping for malaria control in western Kenya: study protocol for a stepped wedge cluster-randomised trial
    Alexandra Hiscox
    Tobias Homan
    Collins K. Mweresa
    Nicolas Maire
    Aurelio Di Pasquale
    Daniel Masiga
    Prisca A. Oria
    Jane Alaii
    Cees Leeuwis
    Wolfgang R. Mukabana
    Willem Takken
    Thomas A. Smith
    [J]. Trials, 17
  • [10] Evaluation of California's Armed and Prohibited Persons System: study protocol for a cluster-randomised trial
    Wintemute, Garen J.
    Beckett, Laurel
    Kass, Philip H.
    Tancredi, Daniel
    Studdert, David
    Pierce, Glenn
    Braga, Anthony A.
    Wright, Mona A.
    Cerda, Magdalena
    [J]. INJURY PREVENTION, 2017, 23 (05) : 358 - U103